ENTITY

Emcure Pharmaceuticals (763195Z IN)

11
Analysis
Health CareIndia
Emcure Pharmaceuticals Limited operates as a pharmaceutical company. The Company manufactures tablets, soft-gel and hard-gel capsules, and injectables, as well as vitamins, minerals, and nutrients products. Emcure Pharmaceuticals serves customers worldwide.
more
Refresh
09 Jul 2024 14:14

Emcure Pharma Pre-IPO Trading - Strong Subscription, Will Pop

Emcure Pharmaceuticals raised around US$240m in its India IPO. Subscription rates were strong for institutional and HNI tranche.

Logo
233 Views
Share
03 Jul 2024 10:10

Emcure Pharmaceuticals Pre-IPO - Refiling Updates and Valuations

Emcure Pharmaceuticals is looking to raise around US$240m in its upcoming India IPO. In this note, we talk about valuations.

Logo
2.4k Views
Share
28 Jun 2024 22:24

Emcure Pharmaceuticals Pre-IPO: IPO Price Band Set; Steep Valuation Offers Limited Upside Potential

Emcure Pharmaceuticals seeks to raise INR19.5B through fresh issue of INR8B and an OFS of 11.4M shares. The issue will open for subscription on...

Logo
513 Views
Share
22 Dec 2023 09:30

Emcure Pharmaceuticals Pre-IPO: IPO Size Trimmed; Domestic Revenue Growth Decelerated

Emcure has re-flied DRHP for the second time and is looking to raise $400–500M through fresh issue and an OFS of ~14M shares. IPO proceeds will be...

Logo
749 Views
Share
15 Jul 2024 08:48

ECM Weekly (15th July 2024) - Kokusai, Wiwynn, Kelun-Biotech, Timee, Shift Up, Sanil, Avanse

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
294 Views
Share
x